Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 2/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.42 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.39 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.37 |
| ▸ | MEN1 | O00255 | 4/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.35 |
| ▸ | F2 | P00734 | 1/20 | 0.34 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.34 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.34 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19421 | 0.83 | MEN1 (0.41) | CYP1A2CYP2C19CYP2D6CYP2C9KMT2A | |
| SCHEMBL6553778 | 0.82 | CYP1A2 (0.42) | CYP1A2CYP2C19CYP2D6CYP2C9KMT2A | |
| SCHEMBL150729 | 0.82 | MEN1 (0.41) | CYP1A2CYP2C19CYP2D6CYP2C9KMT2A | |
| SCHEMBL1768748 | 0.79 | CYP1A2 (0.40) | CYP1A2CYP2C19CYP2D6CYP2C9KMT2A | |
| Methylamine SCHEMBL27521765 | 0.73 | MEN1 (0.41) | CYP1A2CYP2C19CYP2D6CYP2C9KMT2A | |
| SCHEMBL20455791 | 0.72 | KMT2A (0.44) | CYP1A2CYP2C19CYP2D6CYP2C9KMT2A | |
| SCHEMBL345420 | 0.71 | TRPM8 (0.37) | CYP1A2CYP2C19ALDH1A1LMNA | |
| SCHEMBL44530 | 0.68 | CYP2C19 (0.42) | CYP1A2CYP2C19CYP2D6CYP2C9KMT2A | |
| Camphor SCHEMBL27571091 | 0.68 | MEN1 (0.61) | CYP1A2CYP2C19CYP2D6CYP2C9KMT2A | |
| SCHEMBL10636182 | 0.68 | HPGD (0.36) | CYP1A2CYP2C19KMT2AMEN1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109069384-B | 10-hydroxystearic acid composition | 帝斯曼知识产权资产管理有限公司 | 2022-10-18 | — | — | CN | disclosed |
| CN-109069381-B | 10-hydroxystearic acid composition | 帝斯曼知识产权资产管理有限公司 | 2021-11-30 | — | — | CN | disclosed |
| CN-107072902-B | Use of cosmetic compositions comprising 10-hydroxystearic acid | 帝斯曼知识产权资产管理有限公司 | 2021-01-19 | — | — | CN | disclosed |
| EP-1494642-B1 | Organosilicon derivatives of aminohydroxybenzophenones and their use as UV-A filters in cosmetic preparations | DSM IP ASSETS BV (NL) | 2010-03-10 | — | — | EP | disclosed |
| US-7611696-B2 | Sunscreen compositions as well as dihydropyridines and dihydropyranes | DSM IP ASSETS B.V. (NL) | 2009-11-03 | — | — | US | disclosed |
| US-7388102-B2 | Organosilicone derivatives of amino hydroxybenzophenones and their use as UV-A filters in cosmetic preparations | DSM IP ASSETS B.V. (NL) | 2008-06-17 | — | — | US | disclosed |
| US-20080031909-A1 | Encapsulated Cosmetic Materials | DSM IP ASSETS B.V. (NL) | 2008-02-07 | — | — | US | disclosed |
| US-20070270472-A1 | Amino, Amino Acid or Peptide Conjugates of Retinoic Acid | DSM IP ASSETS B.V. (NL) | 2007-11-22 | — | — | US | disclosed |
| EP-1838428-A1 | ENCAPSULATED COSMETIC MATERIALS | DSMIP Assets B.V. (NL) | 2007-10-03 | — | — | EP | disclosed |
| EP-1765773-A2 | AMINO, AMINO ACID OR PEPTIDE CONJUGATES OF RETINOIC ACID | DSMIP Assets B.V. (NL) | 2007-03-28 | — | — | EP | disclosed |
| EP-1474098-B1 | SUNSCREEN COMPOSITIONS AS WELL AS DIHYDROPYRIDINES AND DIHYDROPYRANES | DSM IP ASSETS BV (NL) | 2006-08-02 | — | — | EP | disclosed |
| WO-2006061124-A1 | ENCAPSULATED COSMETIC MATERIALS | DSM IP ASSETS B.V. (NL) | 2006-06-15 | — | — | WO | disclosed |
| WO-2006005455-A2 | AMINO, AMINO ACID OR PEPTIDE CONJUGATES OF RETINOIC ACID | DSM IP ASSETS B.V. (NL) | 2006-01-19 | — | — | WO | disclosed |
| US-20050255066-A1 | Organosilicone derivatives of amino hydroxybenzophenones and their use as uv-a filters in cosmetic preparations | DSM NUTRITIONAL PRODUCTS LTD F/K/A ROCHE VITAMINS AG (CH) | 2005-11-17 | — | — | US | disclosed |
| US-20050019278-A1 | Sunscreen compositions as well as dihydropyridines and dihydropyranes | ROCHE VITAMINS AG (CH) | 2005-01-27 | — | — | US | disclosed |
| EP-1474098-A1 | SUNSCREEN COMPOSITIONS AS WELL AS DIHYDROPYRIDINES AND DIHYDROPYRANES | DSM IP Assets B.V. (NL) | 2004-11-10 | — | — | EP | disclosed |
| WO-2003068183-A1 | SUNSCREEN COMPOSITIONS AS WELL AS DIHYDROPYRIDINES AND DIHYDROPYRANES | DSM IP ASSETS B.V. (NL) | 2003-08-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070270472-A1 | Amino, Amino Acid or Peptide Conjugates of Retinoic Acid | RARA, RARG, RARB | CYP1A2 4405/4885CYP2C19 4653/4885CYP2D6 4695/4885 |
| US-20050255066-A1 | Organosilicone derivatives of amino hydroxybenzophenones and their use as uv-a filters in cosmetic preparations | CUTA, TYR, ERCC5 | CYP1A2 450/4885CYP2C19 364/4885CYP2D6 710/4885 |
| US-20050019278-A1 | Sunscreen compositions as well as dihydropyridines and dihydropyranes | DHPS, DSG1, DHODH | CYP1A2 515/4885CYP2C19 1130/4885CYP2D6 483/4885 |
| US-20080031909-A1 | Encapsulated Cosmetic Materials | H1-5, ADGRE5, KAT5 | CYP1A2 1915/4885CYP2C19 1625/4885CYP2D6 2096/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.